MBII
Price:
$0.7981
Market Cap:
$0
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil...[Read more]
Industry
Agricultural Inputs
IPO Date
2013-08-02
Stock Exchange
NASDAQ
Ticker
MBII
According to Marrone Bio Innovations, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.87M. This represents a change of -91.62% compared to the average of 213.12M of the last 4 quarters.
The mean historical Enterprise Value of Marrone Bio Innovations, Inc. over the last ten years is 140.18M. The current 17.87M Enterprise Value has changed 1.17% with respect to the historical average. Over the past ten years (40 quarters), MBII's Enterprise Value was at its highest in in the March 2021 quarter at 369.01M. The Enterprise Value was at its lowest in in the June 2012 quarter at 0.
Average
140.18M
Median
139.59M
Minimum
64.91M
Maximum
299.77M
Discovering the peaks and valleys of Marrone Bio Innovations, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 59.84%
Maximum Annual Enterprise Value = 299.77M
Minimum Annual Increase = -52.85%
Minimum Annual Enterprise Value = 64.91M
Year | Enterprise Value | Change |
---|---|---|
2021 | 143.78M | -27.51% |
2020 | 198.35M | 45.90% |
2019 | 135.96M | -10.59% |
2018 | 152.05M | 59.84% |
2017 | 95.13M | -5.88% |
2016 | 101.07M | 55.72% |
2015 | 64.91M | -3.89% |
2014 | 67.53M | -52.85% |
2013 | 143.22M | -52.22% |
2012 | 299.77M | 20.02% |
The current Enterprise Value of Marrone Bio Innovations, Inc. (MBII) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
159.36M
5-year avg
145.05M
10-year avg
140.18M
Marrone Bio Innovations, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marrone Bio Innovations, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Marrone Bio Innovations, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Marrone Bio Innovations, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Marrone Bio Innovations, Inc. (MBII)?
What is the 3-year average Enterprise Value for Marrone Bio Innovations, Inc. (MBII)?
What is the 5-year average Enterprise Value for Marrone Bio Innovations, Inc. (MBII)?
How does the current Enterprise Value for Marrone Bio Innovations, Inc. (MBII) compare to its historical average?